I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Proliferative activity of antigen-specific CD154+ T cells a..:
Eschenhagen, Patience N
;
Bacher, Petra
;
Grehn, Claudia
...
Frontiers in pharmacology -- Front. Pharmacol. -- 1663-9812. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1180826
RT Journal T1
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy
UL https://suche.suub.uni-bremen.de/peid=base-ftunivkiel:oai:macau.uni-kiel.de:macau_mods_00004336&Exemplar=1&LAN=DE A1 Eschenhagen, Patience N A1 Bacher, Petra A1 Grehn, Claudia A1 Mainz, Jochen G A1 Scheffold, Georg Alexander A1 Schwarz, Carsten PB Frontiers Media SA YR 2023 K1 article K1 ScholarlyArticle K1 Published Version K1 ddc:610 K1 Pseudomonas aeruginosa K1 Aspergillus fumigatus K1 Ki-67 K1 Total IgE K1 Cystic Fibrosis K1 Antigen-specific T Cells K1 Total Igg K1 Highly Effective Modulator Therapy JF Frontiers in pharmacology -- Front. Pharmacol. -- 1663-9812 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1180826 DO https://doi.org/10.3389/fphar.2023.1180826 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)